NIPH Clinical Trials Search

Basic Information

Recruitment status
Health condition(s) or Problem(s) studied	Primary open-angle glaucoma (POAG)
Date of first enrollment	21/04/2013
Target sample size	60
Countries of recruitment
Study type	Interventional
Intervention(s)	investigational material(s) Generic name etc : brimonidine tartrate INN of investigational material : Therapeutic category code : 131 Agents for ophthalmic use Dosage and Administration for Investigational material : Ocular administration control material(s) Generic name etc : timolol maleate INN of investigational material : Therapeutic category code : 131 Agents for ophthalmic use Dosage and Administration for Investigational material : Ocular administration

Outcome(s)

Primary Outcome	retinal sensitivity progression of retinal sensitivity using Humphrey Field Analyzer
Secondary Outcome	intraocular pressure(IOP) Optical coherence tomographic(OCT) finding retinal perfusion change of IOP retinal change using OCT change of retinal perfusion using Laser Speckle Flowgraphy

Key inclusion & exclusion criteria

Age minimum	>= 20age old
Age maximum	Not applicable
Gender	Both
Include criteria	Patients had POAG Mean deviation>=-20dB IOP<=21.0mmHg Best corrected visual acuity of 0.5 or better
Exclude criteria	Any active ocular disease Active retinal disease Ocular surgery within 3 months History of trabeculotomy or trabeculectom